Background: Anti-phosphatidylserine/prothrombin (aPS/PT) antibodies have begun to be
considered potentional biomarkers for antiphospholipid syndrome (APS). This cohort study …

Background: Antiphosphatidylserine/prothrombin complex (aPS/PT) antibodies are
emerging as an important marker for antiphospholipid syndrome (APS). We aimed to …

Background: The aim of the study was to determine the prevalence and clinical associations
of antiphosphatidylserine/prothrombin antibodies (aPS/PT) with thrombosis and pregnancy …

Antiprothrombin antibodies, measured with phosphatidylserine/prothrombin complex
(aPS/PT) ELISA, have been reported to be associated with antiphospholipid syndrome …

The antiphospholipid antibodies present in antiphospholipid syndrome (APS) are directed at
a number of phospholipid-binding proteins: β2 glycoprotein I (β2GPI), prothrombin, and so …

BACKGROUND: To clarify the association and diagnostic utility of measuring
antiphosphatidyl serine (aPS), antiprothrombin (aPT) and the antiphosphatidyl …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence
of antiphospholipid antibodies (aPLs), which can lead to thrombosis and pregnancy …

Objective The clinical significance of anti-phosphatidylserine/prothrombin (aPS/PT) in
antiphospholipid syndrome (APS) is still controversial. We assessed the prevalence of …

Objective The aim of the study is to perform a systematic review on the recent available
evidence on antiphosphatidylserine/prothrombin (aPS/PT) antibodies and their association …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by thrombosis
and/or pregnancy-related morbidity accompanied by persistently positive antiphospholipid …